Which adverse effect is listed for evinacumab?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which adverse effect is listed for evinacumab?

When evaluating adverse effects of evinacumab, the safety labeling emphasizes immune-mediated reactions because it is a monoclonal antibody. Severe hypersensitivity reactions, including anaphylaxis, have been reported with evinacumab. This makes severe hypersensitivity the standout adverse effect that is explicitly listed and clinically important. While headaches, nausea, and nasopharyngitis can occur with many therapies and may be seen with evinacumab, they are less distinctive and less impactful from a safety-significance standpoint. Thus, the adverse effect that is listed with notable clinical seriousness for evinacumab is severe hypersensitivity reactions.

When evaluating adverse effects of evinacumab, the safety labeling emphasizes immune-mediated reactions because it is a monoclonal antibody. Severe hypersensitivity reactions, including anaphylaxis, have been reported with evinacumab. This makes severe hypersensitivity the standout adverse effect that is explicitly listed and clinically important. While headaches, nausea, and nasopharyngitis can occur with many therapies and may be seen with evinacumab, they are less distinctive and less impactful from a safety-significance standpoint. Thus, the adverse effect that is listed with notable clinical seriousness for evinacumab is severe hypersensitivity reactions.

More practice questions